UPSTREAM CONSULTING

Lobbying for ZIONS THERAPEUTICS · Research and treatment development for Endophthalmitis.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Utah · House · Senate · $15,000.00 income · posted Jul 17, 2026

Lobbying activity 1

Health Issues

Access to eye treatments.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem